Q3 2025 Management View CEO Kevin Smith reported, "this quarter marked our seventh consecutive period of mid-single-digit revenue growth as we delivered over $92 million in total revenue." Smith noted ...

Main Clinic Supply (1-888-850-9017) is broadening patient access to lightweight portable oxygen concentrators designed for travel and active lifestyles.

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has ...

Inogen (INGN) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to a loss of $0.25 per share a year ago. These figures are adjusted ...

GOLETA, Calif. (AP) — GOLETA, Calif. (AP) — Inogen Inc. (INGN) on Wednesday reported a loss of $5.3 million in its third quarter. On a per-share basis, the Goleta, California-based company said it had ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has ...

Inogen, Inc. INGN recently announced the launch of its Inogen One G5 portable oxygen concentrator. The product is now available for sale through the company’s domestic direct-to-consumer sales channel ...

Inogen, Inc. INGN has been gaining on the back of its high prospects in the portable oxygen concentrator (POC) space. Solid performance in the second quarter of 2022 and a strong product portfolio ...

With a new CEO in place and its revenues on the rebound after a tumultuous 2020, Inogen is looking to make its product line of at-home and portable oxygen concentrators bigger and better than ever.

Needham analyst Mike Matson downgraded the rating on Inogen, Inc (NASDAQ:INGN) to Hold from Buy, with a price target of $26. INGN announced it is acquiring privately-held Physio-Assist SAS for $32 ...